epirubicin has been researched along with Obesity in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Champagne, C; Gaillot-Petit, N; Guilbert, P; Lamberth, F; Looten-Vieren, L; Nguyen, TD | 1 |
| Bonnetain, F; Dalban, C; Ecarnot, F; Fumoleau, P; Ghiringhelli, F; Ladoire, S; Levy, C; Martin, AL; Roché, H; Spielmann, M | 1 |
| Carroll, JP; Cheng, ME; Fay, M; Martin, JH; Nguyen, L; Pillay, PS; Protani, MM; Saleem, M; Walpole, E | 1 |
| Cihan, YB | 1 |
| Denkert, C; Eiermann, W; Furlanetto, J; Lederer, B; Loibl, S; Marmé, F; Möbus, V; Nekljudova, V; Reimer, T; Reinisch, M; Schmatloch, S; Stickeler, E; Thomssen, C; Untch, M; von Minckwitz, G; Weber, K | 1 |
| Mathew, J; Odell, JA; Stauffer, JA | 1 |
| Bernáldez-Ríos, R; Espinoza-Hernández, L; Fajardo-Gutíerrez, A; Martínez-García, MC; Mejía-Arangure, JM; Rodríguez-Zepeda, MC | 1 |
| Bjarnason, GA; Franssen, E; Madarnas, Y; Sawka, CA | 1 |
| Bengtsson, NO; Eksborg, S; Elfsson, B; Hardell, L; Sjödin, M | 1 |
2 trial(s) available for epirubicin and Obesity
| Article | Year |
|---|---|
Effect of obesity on disease-free and overall survival in node-positive breast cancer patients in a large French population: a pooled analysis of two randomised trials.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Obesity; Prognosis; Proportional Hazards Models; Survival Analysis; Taxoids; Treatment Outcome; Young Adult | 2014 |
Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Body Surface Area; Breast Neoplasms; Capecitabine; Cyclophosphamide; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Febrile Neutropenia; Female; Humans; Lymphatic Metastasis; Obesity; Taxoids | 2016 |
7 other study(ies) available for epirubicin and Obesity
| Article | Year |
|---|---|
[Potential indications for helical tomotherapy in breast cancers].
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Funnel Chest; Hodgkin Disease; Humans; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Obesity; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Taxoids | 2014 |
Toxicity and tolerability of adjuvant breast cancer chemotherapy in obese women.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Body Size; Body Surface Area; Breast Neoplasms; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Multivariate Analysis; Obesity; Odds Ratio; Retrospective Studies; Taxoids | 2014 |
Relationship of body mass index with prognosis in breast cancer patients treated with adjuvant radiotherapy and chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Axilla; Body Mass Index; Breast Neoplasms; Breast Neoplasms, Male; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mastectomy, Modified Radical; Middle Aged; Neoplasm Metastasis; Obesity; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Thinness; Treatment Outcome | 2014 |
Esophageal adenocarcinoma after laparoscopic gastric band placement for obesity.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bariatric Surgery; Deglutition Disorders; Disease Progression; Epirubicin; Esophageal Neoplasms; Fatal Outcome; Fluorouracil; Gastroesophageal Reflux; Humans; Male; Obesity; Organoplatinum Compounds; Oxaliplatin | 2011 |
Nutritional state alterations in children with acute lymphoblastic leukemia during induction and consolidation of chemotherapy.
Topics: Adolescent; Anthropometry; Antineoplastic Combined Chemotherapy Protocols; Arm; Asparaginase; Body Constitution; Child; Child, Preschool; Cohort Studies; Cytarabine; Drug Administration Schedule; Energy Metabolism; Epirubicin; Female; Gastrointestinal Diseases; Hospitals, General; Hospitals, Pediatric; Humans; Infant; Male; Mercaptopurine; Methotrexate; Nutrition Disorders; Nutritional Status; Obesity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk; Skinfold Thickness; Vincristine | 1997 |
Are medical oncologists biased in their treatment of the large woman with breast cancer?
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Attitude of Health Personnel; Body Mass Index; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Medical Oncology; Methotrexate; Middle Aged; Obesity; Ontario; Practice Patterns, Physicians'; Prejudice; Retrospective Studies | 2001 |
Epirubicin as a single agent therapy for the treatment of breast cancer--a pharmacokinetic and clinical study.
Topics: Adult; Aged; Body Weight; Breast Neoplasms; Epirubicin; Female; Humans; Middle Aged; Neoplasm Metastasis; Obesity; Remission Induction | 1992 |